Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""STEM cell transplantation"" wg kryterium: Temat


Tytuł:
Early M-protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high-risk cytogenetic multiple myeloma.
Autorzy:
Zhu H; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Liu J; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Gu J; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Chen M; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Kuang L; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Huang B; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Zou W; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Li J; Haematology, Sun Yat-sen University First Affiliated Hospital, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 976-987. Date of Electronic Publication: 2024 Jan 21.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*
Immune Reconstitution*
Hematopoietic Stem Cell Transplantation*/methods
Humans ; Prognosis ; Cytogenetic Analysis ; Transplantation, Autologous ; Retrospective Studies ; Stem Cell Transplantation ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxis.
Autorzy:
Stavi V; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Allogeneic Transplant Unit, Soroka University Medical Centre, Beersheba, Israel.
Desai N; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Michelis FV; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Kim DDH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Kumar R; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Lipton JH; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Law AD; Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 433-438. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Pneumonia, Pneumocystis*/diagnosis
Pneumonia, Pneumocystis*/etiology
Pneumonia, Pneumocystis*/prevention & control
Pneumocystis carinii*
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Antilymphocyte Serum/therapeutic use ; Stem Cell Transplantation/adverse effects ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.
Autorzy:
Jia X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Liao N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Yu S; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Li H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Liu H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Zhang H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Xu J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Yao Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
He H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Yu G; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Shi P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7074.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Leukemia, Myeloid, Acute*/metabolism
Adult ; Humans ; Transplantation, Homologous ; Stem Cell Transplantation ; Recurrence ; Pathologic Complete Response ; Neoplasm, Residual ; Retrospective Studies ; Prognosis
Czasopismo naukowe
Tytuł:
Comparison of Stem Cell Transplantation Using Unrelated, Haploidentical, and Sibling Donors for Patients with Acquired Severe Aplastic Anemia: A Single-Center Retrospective Cohort Study.
Autorzy:
Fu W; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Gao S; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Luo Y; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Chen L; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Chen J; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Gao L; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Wang L; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Xu L; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Wang Y; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Wang Z; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Yue W; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Cheng H; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Tang G; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China.
Wang J; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China. Electronic address: .
Yang J; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China. Electronic address: .
Ni X; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai 200433, China. Electronic address: .
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Feb; Vol. 30 (2), pp. 245.e1-245.e8. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Aplastic*/therapy
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Adult ; Retrospective Studies ; Siblings ; Stem Cell Transplantation
Czasopismo naukowe
Tytuł:
Reduced mitochondrial respiration in peripheral T cells after paediatric heamatopoietic stem cell transplantation.
Autorzy:
Mølgaard K; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Copenhagen, Denmark.
Kielsen K; Institute of Inflammatory Research, Rigshospitalet, Copenhagen, Denmark.
Ifversen M; Hematopietic Stem Cell Transplantation and Primary Immune Deficiency, Department of Paediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Met Ö; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Copenhagen, Denmark.
Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital, Copenhagen, Denmark.
Müller K; Institute of Inflammatory Research, Rigshospitalet, Copenhagen, Denmark.; Hematopietic Stem Cell Transplantation and Primary Immune Deficiency, Department of Paediatric and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 10; Vol. 14, pp. 1327977. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Respiratory Insufficiency*
Humans ; Child ; Leukocytes, Mononuclear ; T-Lymphocytes ; Stem Cell Transplantation ; Respiration
Czasopismo naukowe
Tytuł:
Comparison of autologous, matched sibling, and alternative donor stem cell transplant outcomes for acute myeloid leukemia patients in first remission: A propensity score matching study.
Autorzy:
Wang M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zhang H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zheng X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Liu J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Cao Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zhang X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zhang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Chen X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Zhai W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Ma Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Huang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Yang D; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Pang A; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.
Pokaż więcej
Źródło:
Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3230. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/therapy
Hematopoietic Stem Cell Transplantation*/methods
Humans ; Siblings ; Propensity Score ; Tissue Donors ; Stem Cell Transplantation ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities.
Autorzy:
Guman T
Sykora J
Pokaż więcej
Źródło:
Bratislavske lekarske listy [Bratisl Lek Listy] 2024; Vol. 125 (1), pp. 9-11.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/methods
Multiple Myeloma*/genetics
Multiple Myeloma*/therapy
Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chromosome Aberrations ; Disease Progression ; Disease-Free Survival ; Progression-Free Survival ; Retrospective Studies ; Stem Cell Transplantation ; Transplantation, Autologous ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care.
Autorzy:
Bostankolu Değirmenci B; Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey.
Yegin ZA; Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey. .
Akdemir ÜÖ; Department of Nuclear Medicine, Gazi University Faculty of Medicine, Ankara, Turkey.
Dede A; Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey.
Gündem GG; Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey.
Özkurt ZN; Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey.
Atay LÖ; Department of Nuclear Medicine, Gazi University Faculty of Medicine, Ankara, Turkey.
Yağcı M; Department of Hematology, Gazi University Faculty of Medicine, Ankara, Turkey.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Jan; Vol. 103 (1), pp. 269-283. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*/therapy
Multiple Myeloma*/drug therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Male ; Female ; Middle Aged ; Transplantation, Autologous ; Retrospective Studies ; Positron Emission Tomography Computed Tomography ; Standard of Care ; Transplantation Conditioning ; Melphalan/therapeutic use ; Stem Cell Transplantation ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
Autorzy:
Baech J; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Husby S; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Trab T; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Kragholm K; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Brown P; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Gørløv JS; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
Jørgensen JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
Gudbrandsdottir S; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
Severinsen MT; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Grønbaek K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Larsen TS; Department of Hematology, Odense University Hospital, Odense, Denmark.
Wästerlid T; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Eloranta S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Smeland KB; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Jakobsen LH; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
El-Galaly TC; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.; Department of Hematology, Odense University Hospital, Odense, Denmark.; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 967-975. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*
Lymphoma*
Hematopoietic Stem Cell Transplantation*
Humans ; Male ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Transplantation, Autologous ; Stem Cell Transplantation ; Denmark
Czasopismo naukowe
Tytuł:
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Autorzy:
Jullien M; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France.
Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France.
Garnier A; Hematology Department, Nantes University Hospital, Nantes, France.
Eveillard M; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Le Bris Y; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Bouzy S; Hematology Biology, Nantes University Hospital, Nantes, France.
Tessoulin B; Hematology Department, Nantes University Hospital, Nantes, France.
Gastinne T; Hematology Department, Nantes University Hospital, Nantes, France.
Dubruille V; Hematology Department, Nantes University Hospital, Nantes, France.
Touzeau C; Hematology Department, Nantes University Hospital, Nantes, France.
Mahé B; Hematology Department, Nantes University Hospital, Nantes, France.
Blin N; Hematology Department, Nantes University Hospital, Nantes, France.
Lok A; Hematology Department, Nantes University Hospital, Nantes, France.
Vantyghem S; Hematology Department, Nantes University Hospital, Nantes, France.
Sortais C; Hematology Department, Nantes University Hospital, Nantes, France.
Antier C; Hematology Department, Nantes University Hospital, Nantes, France.
Moreau P; Hematology Department, Nantes University Hospital, Nantes, France.
Scotet E; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Béné MC; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.; Hematology Biology, Nantes University Hospital, Nantes, France.
Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France.; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; LabEx IGO 'Immunotherapy, Graft, Oncology', Nantes, France.
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 350-359. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/methods
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Graft vs Host Disease*/drug therapy
Humans ; Interleukin-2 ; Zoledronic Acid ; T-Lymphocytes/pathology ; Cyclophosphamide/therapeutic use ; Stem Cell Transplantation
Czasopismo naukowe
Tytuł:
Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant.
Autorzy:
Begna KH; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester. .
Abdallah NH; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester.
Janania-Martinez M; Division of Hematology/Oncology, Sanford Cancer Center, Sioux Falls, SD USA.
Mangaonkar AA; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester.
Rangan A; Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester.
Herrick JL; Department of Laboratory medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester.
Gangat N; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2024 Feb 01; Vol. 109 (2), pp. 689-692. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Immunoconjugates*/therapeutic use
Antibodies, Monoclonal*
Humans ; Brentuximab Vedotin ; Stem Cell Transplantation ; T-Lymphocytes
Czasopismo naukowe
Tytuł:
Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation.
Autorzy:
Afzali-Hashemi L; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.
Dovern E; Department of Hematology, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.
Baas KPA; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.
Schrantee A; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.
Wood JC; Division of Cardiology, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Nederveen AJ; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.
Nur E; Department of Hematology, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.; Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
Biemond BJ; Department of Hematology, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2024 Feb; Vol. 99 (2), pp. 163-171. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Sickle Cell*
Hematopoietic Stem Cell Transplantation*/adverse effects
Adult ; Female ; Humans ; Hemolysis ; Magnetic Resonance Imaging/methods ; Hemodynamics ; Oxygen/metabolism ; Stem Cell Transplantation ; Hemoglobins/metabolism ; Cerebrovascular Circulation/physiology ; Brain/diagnostic imaging ; Brain/metabolism ; Oxygen Consumption
Czasopismo naukowe
Tytuł:
Retinitis Pigmentosa: From Pathomolecular Mechanisms to Therapeutic Strategies.
Autorzy:
Vingolo EM; Sense Organs Department, UOSD of Ophtalmology, University la Sapienza of Rome, Polo Pontino-Ospedale A. Fiorini, 4019 Terracina, Italy.
Mascolo S; Sense Organs Department, UOSD of Ophtalmology, University la Sapienza of Rome, Polo Pontino-Ospedale A. Fiorini, 4019 Terracina, Italy.
Miccichè F; Sense Organs Department, UOSD of Ophtalmology, University la Sapienza of Rome, Polo Pontino-Ospedale A. Fiorini, 4019 Terracina, Italy.
Manco G; Sense Organs Department, UOSD of Ophtalmology, University la Sapienza of Rome, Polo Pontino-Ospedale A. Fiorini, 4019 Terracina, Italy.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Jan 22; Vol. 60 (1). Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Retinitis Pigmentosa*/therapy
Retinitis Pigmentosa*/genetics
Hyperbaric Oxygenation*
Hematopoietic Stem Cell Transplantation*
Humans ; Stem Cell Transplantation ; Genetic Therapy
Czasopismo naukowe
Tytuł:
Outcome of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients.
Autorzy:
Alzahrani RS; Infectious Diseases Division, Internal Medicine Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. Electronic address: .
Alzahrani M; Divisions of Adult Hematology and SCT, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Shuraim W; Infectious Diseases Division, Internal Medicine Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia.
Aldibasi O; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Albarrak K; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Habib A; Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Ahmed M; Divisions of Adult Hematology and SCT, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alsadi H; Divisions of Adult Hematology and SCT, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alahmari B; Divisions of Adult Hematology and SCT, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alsaedy A; Infectious Diseases Division, Internal Medicine Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Bosaeed M; Infectious Diseases Division, Internal Medicine Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Transplantation proceedings [Transplant Proc] 2024 Jan-Feb; Vol. 56 (1), pp. 186-190. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Respiratory Tract Infections*/diagnosis
Respiratory Tract Infections*/epidemiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Virus Diseases*/epidemiology
Adult ; Humans ; Female ; Retrospective Studies ; Stem Cell Transplantation ; Transplant Recipients
Czasopismo naukowe
Tytuł:
Drug monitoring during ciprofloxacin prophylaxis of allogeneic stem cell transplant patients: associations with bacterial infections through a monocentric observational prospective study.
Autorzy:
Kaba HEJ; Department of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Hasenkamp J; Department of Haematology and Medical Oncology, Göttingen Comprehensive Cancer Centre, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Tas H; Department of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany; Department of Haematology and Medical Oncology, Göttingen Comprehensive Cancer Centre, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Schulz M; Department of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Streit F; Institute for Clinical Chemistry, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Eiffert H; Institute of Medical Microbiology and Virology, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany; mbeds Holding GmbH, Göttingen, Germany.
Wulf G; Department of Haematology and Medical Oncology, Göttingen Comprehensive Cancer Centre, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Truemper L; Department of Haematology and Medical Oncology, Göttingen Comprehensive Cancer Centre, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Binder L; Institute for Clinical Chemistry, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Kaase M; Department of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany.
Scheithauer S; Department of Infection Control and Infectious Diseases, University Medical Centre Göttingen, Georg-August University of Göttingen, Göttingen, Germany. Electronic address: .
Pokaż więcej
Źródło:
The Journal of hospital infection [J Hosp Infect] 2024 Jan; Vol. 143, pp. 160-167. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Bacterial Infections*/drug therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Sepsis*/microbiology
Bacteremia*/microbiology
Gram-Negative Bacterial Infections*/microbiology
Adult ; Humans ; Ciprofloxacin/therapeutic use ; Prospective Studies ; Drug Monitoring ; Stem Cell Transplantation ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation.
Autorzy:
Shingai N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan. Electronic address: .
Ota A; Division of Nephrology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kato K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kondo K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Sadaga Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kato C; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Sakai S; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kambara Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Nabe Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Asano K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Teshima K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kurihara K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Ouchi F; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Fujiwara H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Shimabukuro M; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Inai K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Jinguji A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Shimizu H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Sugaya T; Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.
Ando M; Department of Medicine, Jiseikai Memorial Hospital, Itabashi-ku, Tokyo, Japan.
Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Pokaż więcej
Źródło:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jan; Vol. 30 (1), pp. 121.e1-121.e8. Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Fatty Acid-Binding Proteins*/urine
Hematopoietic Stem Cell Transplantation*
Adult ; Humans ; Prospective Studies ; Follow-Up Studies ; Biomarkers/urine ; Prognosis ; Stem Cell Transplantation ; Liver
Czasopismo naukowe
Tytuł:
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.
Autorzy:
Davis JA; Division of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA. .
Thurlapati A; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Weeda E; Medical University of South Carolina College of Pharmacy, Charleston, SC, USA.
Gaffney KJ; Division of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Smith D; Division of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Maldonado A; Division of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Granger K; Division of Malignant Hematology and Bone Marrow Transplant, Department of Pharmacy, Medical University of South Carolina, 86 Jonathan Lucas St, Charleston, SC, 29425, USA.
Martin KE; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Williams YM; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Herrington T; Medical University of South Carolina College of Pharmacy, Charleston, SC, USA.
Velayati A; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Bakos JK; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Green K; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Hashmi H; Department of Hematology and Bone Marrow Transplant, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Jan; Vol. 103 (1), pp. 251-258. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*/therapy
Multiple Myeloma*/drug therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Ethnicity ; Disease-Free Survival ; Transplantation, Autologous ; Antineoplastic Combined Chemotherapy Protocols ; Stem Cell Transplantation ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Low-intensity venetoclax-based salvage as a bridge to allogeneic stem cell transplant in patients with acute myeloid leukemia failing conventional intensive chemotherapy.
Autorzy:
Ashby M; Alfred Hospital and Monash University, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, Monash University, Australia.
Fleming S; Alfred Hospital and Monash University, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, Monash University, Australia.
Teh TC; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Tiong IS; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Inam S; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Curtis DJ; Alfred Hospital and Monash University, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, Monash University, Australia.
Patil S; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Vassili C; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Chua CC; Alfred Hospital and Monash University, Melbourne, Victoria, Australia; Australian Centre for Blood Diseases, Monash University, Australia; Northern Hospital, Epping, Victoria, Australia. Electronic address: .
Pokaż więcej
Źródło:
Leukemia research [Leuk Res] 2024 Jan; Vol. 136, pp. 107429. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Letter
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Hematopoietic Stem Cell Transplantation*
Sulfonamides*
Humans ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Stem Cell Transplantation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Opinia redakcyjna
Tytuł:
Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders.
Autorzy:
Gorur V; William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ, UK. Electronic address: .
Kranc KR; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ, UK. Electronic address: .
Ganuza M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ, UK. Electronic address: .
Telfer P; Blizard Institute, Queen Mary University of London, E1 2AT, UK. Electronic address: .
Pokaż więcej
Źródło:
Blood reviews [Blood Rev] 2024 Jan; Vol. 63, pp. 101137. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Anemia, Sickle Cell*/therapy
Anemia, Sickle Cell*/pathology
Hematologic Diseases*
Hematopoietic Stem Cell Transplantation*/adverse effects
Humans ; Hematopoietic Stem Cells/pathology ; Stem Cell Transplantation
Czasopismo naukowe
Tytuł:
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?
Autorzy:
Hashmi SK; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. .; Department of Medicine, Sheikh Shakbout Medical City, Abu Dhabi, UAE. .; College of Medicine & Health Sciences, Khalifa University, Abu Dhabi, UAE. .
Powles RC; Cancer Centre London, 49 Parkside, Wimbledon, London, SW19 5NB, UK.
Ma D; Department of Haematology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
Muhsen IN; Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Niederwieser D; University of Leipzig, Leipzig, Germany.; Aichi Medical University, Nagakute, Japan.
Weisdorf DJ; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.
Koh MBC; Infection and Immunity Clinical Academic Group, St George's University of London, London, UK.; Department of Haematology, St George's University Hospitals, London, UK.; Cell Therapy Programme, Health Sciences Authority, Outram, Singapore.
Greinix H; Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Pokaż więcej
Źródło:
Annals of hematology [Ann Hematol] 2024 Apr; Vol. 103 (4), pp. 1121-1129. Date of Electronic Publication: 2023 Jun 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Radiation Injuries*/epidemiology
Radiation Injuries*/etiology
Humans ; Nuclear Power Plants ; Bone Marrow ; Ukraine/epidemiology ; Stem Cell Transplantation
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies